3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
11
Lung Neoplasms
4
Neoplasms
2
Desmoplastic Small Round Cell Tumor
2
Sarcoma, Ewing
1
Sarcoma
1
Platinum-Resistant Lung Small Cell Carcinoma
1
Neutropenia
1
Leiomyosarcoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Carcinoma, Small Cell
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
sacituzumab govitecan
1
amrubicin
1
Topotecan
1
PM 01183
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
×
PM 01183
×
90 days
×
Clear all
NCT06801834
2026-05-20
EVOKE-SCLC-04
Gilead Sciences
Phase 3
Recruiting
695 enrolled